DIAMOND

Owner

Goods & Services

Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of neurological diseases and disorders, central nervous system diseases and disorders, neurodegenerative diseases and disorders, immune system-related diseases and disorders, and metabolic diseases and disorders

Software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of drug discovery and healthcare, biomedical and genomic research; software featuring machine learning and artificial intelligence for data analysis in the fields of drug discovery and healthcare, biomedical and genomic research; software featuring machine learning and artificial intelligence for drug analysis in drug discovery and development; software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks; software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; software for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; software for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement; scientific research, namely, research and analysis services featuring artificial intelligence and machine learning analytics in the fields of healthcare, biomedical and genomic research; research and development in the field of drug discovery and development, computational biology, bioinformatics, and genomics; research and development of pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of neurological diseases and disorders, central nervous system diseases and disorders, neurodegenerative diseases and disorders, immune system-related diseases and disorders, and metabolic diseases and disorders; technical scientific consultation and product development for others in the fields of drug discovery and development, pharmaceuticals, biotechnology and immunology; consulting in the fields of drug discovery and development, clinical trial management and patient engagement in drug clinical trials